Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.297NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AH.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.280NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.597NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.443NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.495NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.294NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.453NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.350NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.304NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.315NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.198NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.366NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20237.1US
B.1.441NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.416NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.263NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.135NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.219NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.208NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.125.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.78 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.159NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.5 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.205NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.177NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.301NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.308NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.210NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.325NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.590NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.116NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.496NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.438.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
AY.49 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.38.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used